EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 4.0

Effect on the Skin Microbiota of Oral Minocycline for Rosacea

Yiyi Zhang, Ying Zhou, Philippe Humbert, Dengfeng Yuan, Chao Yuan

Acta Dermato-Venereologica · 2023

DOI: 10.2340/actadv.v103.10331 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Acta Dermato-Venereologica, 2023. Verfasst von Yiyi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Skin & Cosmetic Research, The Shanghai Skin Disease Hospital of Tongji Medical University, Shanghai 200433, People's Republic of China. Hauptthemen laut MEDLINE: Microbiota, Rosacea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the rosacea an unstable skin microbiota is significant for disease progression. However, data on the influence on the skin microbiota of treatment with systemic antibiotics are limited. This single-arm trial recruited patients with rosacea. Oral minocycline 50 mg was administered twice daily for 6 weeks. The lesions on the cheek and nose were sampled for 16S rRNA amplicon sequencing and metagenomic sequencing at baseline, 3 weeks and 6 weeks of treatment. Physiological parameters were detected using non-invasive instruments. After treatment, distribution of the Investigator Global Assessment scores changed significantly. For the skin microbiota, a notable increase in α-diversity and a shift of structure were observed after treatment. Treatment was accompanied by a reduction in the relative abundance of Cutibacterium and Staphylococcus, indicating negative correlations with increased bacterial metabolic pathways, such as butyrate synthesis and L-tryptophan degradation. The increased butyrate and tryptophan metabolites would be conducive to inhibiting skin inflammation and promoting skin barrier repair. In addition, the abundance of skin bacterial genes related to tetracycline resistance and multidrug resistance increased notably after antibiotic treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaRosaceaHumansAnti-Bacterial AgentsMinocyclineRNA, Ribosomal, 16SSkin

Substanzen

Anti-Bacterial AgentsMinocyclineRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Skin & Cosmetic Research, The Shanghai Skin Disease Hospital of Tongji Medical University, Shanghai 200433, People's Republic of China.
  • R&D Center, Shanghai Jahwa United Co., Ltd., Shanghai 200080, People's Republic of China.
  • University of Franche-Comté, Inserm U1098, Besançon, France.
  • R&D Center, Shanghai Jahwa United Co., Ltd., Shanghai 200080, People's Republic of China. Yuandengfeng@jahwa.com.cn.
  • Department of Skin & Cosmetic Research, The Shanghai Skin Disease Hospital of Tongji Medical University, Shanghai 200433, People's Republic of China. yuanchao0518@hotmail.com.

Zitieren

APA

Zhang, Y., Zhou, Y., Humbert, P., Yuan, D., & Yuan, C. (2023). Effect on the Skin Microbiota of Oral Minocycline for Rosacea. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v103.10331

Vancouver

Zhang Y, Zhou Y, Humbert P, Yuan D, Yuan C. Effect on the Skin Microbiota of Oral Minocycline for Rosacea. Acta Dermato-Venereologica. 2023. doi:10.2340/actadv.v103.10331

BibTeX
@article{Zhang2023,
  author = {Zhang, Yiyi and Zhou, Ying and Humbert, Philippe and Yuan, Dengfeng and Yuan, Chao},
  title = {Effect on the Skin Microbiota of Oral Minocycline for Rosacea},
  journal = {Acta Dermato-Venereologica},
  year = {2023},
  doi = {10.2340/actadv.v103.10331}
}
Kostenlos starten →